Patents by Inventor Marisabel Mourelle Mancini

Marisabel Mourelle Mancini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210121376
    Abstract: The present invention relates to capsules comprising a peptide, lecithin, alginate, and divalent metal cation, compositions comprising said capsules, use thereof in cosmetic treatments, as well as methods of obtaining said capsules.
    Type: Application
    Filed: May 21, 2019
    Publication date: April 29, 2021
    Inventors: Marisabel MOURELLE MANCINI, Aimee VASCONCELOS PACHECO
  • Publication number: 20210015724
    Abstract: The present invention relates to gold nanoparticles conjugated with palmitoyl pentapeptide-4 (Palm-L-Lys-L-Thr-L-Thr-L-Lys-L-Ser-OH), compositions comprising them, use thereof in cosmetic treatments, as well as methods for obtaining said nanoparticles.
    Type: Application
    Filed: March 27, 2019
    Publication date: January 21, 2021
    Inventors: Marisabel MOURELLE MANCINI, Maria Elisa ALEA REYES
  • Publication number: 20180258140
    Abstract: The present invention relates to targeted microcapsules comprising a skin aging compound to target fibroblast with a peptide, which is a FGF receptor agonist, wherein said peptide is coupled to the outer surface of the microcapsule. It also relates to the use of said microcapsules for the cosmetic prevention and/or cosmetic treatment of cutaneous effects of skin aging and to the cosmetic compositions comprising said microcapsules. The invention also relates to the FGF receptor agonist peptide coupled to the microcapsule.
    Type: Application
    Filed: February 24, 2016
    Publication date: September 13, 2018
    Inventors: Marisabel Mourelle Mancini, Luis Javier Cruz Ricondo, Magdalena Carceller Margeli
  • Patent number: 9745346
    Abstract: The present invention relates to a compound of formula (I) and to compositions comprising said compound, as well as the use of said compound and/or said compositions to prevent fungal and/or bacterial growth.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: August 29, 2017
    Assignee: INFINITEC ACTIVOS S.L
    Inventors: Marisabel Mourelle Mancini, Magdalena Carceller Margeli, Luis Javier Cruz Ricondo
  • Publication number: 20170081364
    Abstract: The present invention relates to a compound of formula (I) and to compositions comprising said compound, as well as the use of said compound and/or said compositions to prevent fungal and/or bacterial growth.
    Type: Application
    Filed: March 10, 2015
    Publication date: March 23, 2017
    Applicant: INFINITEC ACTIVOS S.L.
    Inventors: Marisabel Mourelle Mancini, Magdalena Carceller Margeli, Luis Javier Cruz Ricondo
  • Publication number: 20160250128
    Abstract: The present invention relates to targeted microcapsules or nanocapsules comprising a skin whitening compound to target melanocytes with a peptide, which is a MC1 receptor agonist, wherein said peptide is coupled to the outer surface of the microcapsule or nanocapsule. It also relates to the use of said microcapsules or nanocapsules for the cosmetic prevention and/or cosmetic treatment of cutaneous dark spots, and to the cosmetic compositions comprising said microcapsules or nanocapsules. The invention also relates to the MC1 receptor agonist peptide coupled to the microcapsule or nanocapsule. The invention also relates to a peptide for use as skin whitening compound.
    Type: Application
    Filed: November 20, 2014
    Publication date: September 1, 2016
    Inventors: Marisabel Mourelle Mancini, Magdalena Carceller Margeli
  • Publication number: 20130046012
    Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable, stereoisomers, salts or solvates thereof to methods for their synthesis, and use in the treatment of pain.
    Type: Application
    Filed: April 27, 2011
    Publication date: February 21, 2013
    Applicant: LACER, S.A.
    Inventors: Juan Carlos Del Castillo Nieto, Marisabel Mourelle Mancini, Francisco Pubill Coy, José Repollés Moliner
  • Publication number: 20120189616
    Abstract: The present invention relates to new 3-substituted 6-nitrooxy-hexahydrofuro[3,2-b]furane derivatives possessing a superior pharmacological activity in thrombosis and in coronary ischemia models.
    Type: Application
    Filed: April 5, 2012
    Publication date: July 26, 2012
    Applicant: LACER, S.A.
    Inventors: Juan Carlos Del Castillo Nieto, Marisabel Mourelle Mancini, Francisco Pubill Coy, Lydia Cabeza Llorente, Jose Repolles Moliner
  • Patent number: 8211939
    Abstract: The present invention relates to new 3-substituted 6-nitrooxy-hexahydrofuro[3,2-b]furane derivatives possessing a superior pharmacological activity in thrombosis and in coronary ischemia models.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: July 3, 2012
    Assignee: Lacer, S.A.
    Inventors: Juan Carlos Del Castillo Nieto, Marisabel Mourelle Mancini, Francisco Pubill Coy, Lydia Cabeza Llorente, Jose Repolles Moliner
  • Patent number: 8012993
    Abstract: The present invention relates to stable S-nitrosothiols derivatives of formula (I) having vasodilating effect and which inhibit the aggregation of the platelets and which therefore are useful for the preparation of medicaments for treatment of NO related diseases. The invention also relates to a process for the synthesis of the compounds of formula (I).
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: September 6, 2011
    Assignee: Lacer, S.A.
    Inventors: José Repollés Moliner, Francisco Pubill Coy, Marisabel Mourelle Mancini, Juan Carlos del Castillo Nieto, Lydia Cabeza Llorente, Juan Martínez Bonín, Ana Modolell Saladrigas
  • Publication number: 20100022638
    Abstract: The present invention relates to new 3-substituted 6-nitrooxy-hexahydrofuro[3,2-b]furane derivatives possessing a superior pharmacological activity in thrombosis and in coronary ischemia models.
    Type: Application
    Filed: December 15, 2008
    Publication date: January 28, 2010
    Applicant: Lacer, S. A.
    Inventors: Juan Carlos DEL CASTILLO NIETO, Marisabel Mourelle Mancini, Francisco Pubill Coy, Lydia Cabeza Llorente, Jose Repolles Moliner
  • Publication number: 20080161354
    Abstract: The present invention relates to stable S-nitrosothiols derivatives of formula (I) having vasodilating effect and which inhibit the aggregation of the platelets and which therefore are useful for the preparation of medicaments for treatment of NO related diseases. The invention also relates to a process for the synthesis of the compounds of formula (I).
    Type: Application
    Filed: March 1, 2007
    Publication date: July 3, 2008
    Applicant: LACER, S.A.
    Inventors: Jose Repolles Moliner, Francisco Pubill Coy, Marisabel Mourelle Mancini, Juan Carlos del Castillo Nieto, Lydia Cabeza Llorente, Juan Martinez Bonin, Ana Modolell Saladrigas
  • Publication number: 20080161389
    Abstract: The present invention relates to a method of treating an ophthalmological disease mediated by ocular hypertension or an intestinal disorder, comprising administering to a patient in need thereof a therapeutically effective amount of a compound of formula (I) or a tautomer, a pharmaceutically acceptable salt, a prodrug or a solvate thereof.
    Type: Application
    Filed: March 1, 2007
    Publication date: July 3, 2008
    Applicant: LACER, S.A.
    Inventors: Jose Repolles Moliner, Francisco Pubill Coy, Marisabel Mourelle Mancini
  • Patent number: 7001910
    Abstract: The present invention refers to compounds of the general formula (I), to their possible pharmaceutically acceptable salts and tautomeric forms. The present invention also refers to a process for their production and to their use as antidiabetic and *hypoglycemic agents, alone or in combination with other antidiabetic agents, such as sulfonilureas or biguanides, as well as for the treatment of complications associated to the resistance to the insulin, such as hypertension, hyperuricemia or other cardiovascular, metabolic, endocrine conditions, or other conditions related with diabetes.
    Type: Grant
    Filed: November 15, 2000
    Date of Patent: February 21, 2006
    Assignee: Vita-Invest S.A.
    Inventors: Marisabel Mourelle Mancini, Juan Carlos Del Castillo Nieto, Elisabet De Ramon Amat
  • Patent number: 6894076
    Abstract: New esters derived from (RR, SS)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl 2-hydroxybenzoate, analog to Tramadol, a process for obtaining them and the use of these compounds for the production of a medicament with analgesic properties. These new products of general formula (I) exhibit an analgesic activity higher than that of tramadol.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: May 17, 2005
    Assignee: Vita-Invest, S.A.
    Inventors: Marisabel Mourelle Mancini, Elisabet De Ramon Amat, Juan Huguet Clotet
  • Publication number: 20040147545
    Abstract: This invention discloses new fluorquinolonic derivatives of oxazolidinones of general formula (I) and processes for obtaining them, the corresponding pharmaceutical compositions and use thereof for manufacturing a medicament for the treatment of microbial infections. These new compounds are useful as antibacterial agents. Formula (I). Furthermore phenalen-type compounds according to general formula (II) are disclosed. Formula (II).
    Type: Application
    Filed: August 28, 2003
    Publication date: July 29, 2004
    Inventors: Marisabel Mourelle Mancini, Juan Carlos Del Castillo Nieto, Jose Hidalgo Rodriguez, Juan Huguet Clotet
  • Publication number: 20040034219
    Abstract: This invention provides new benzothiophene derivatives of general formula (I) and a process for preparing them, the corresponding compositions and their use for manufacturing a medicine for the treatment of neurological disorders. These new compounds behave as serotonin reuptake inhibitors and show high affinity towards the 5-HT1A receptor.
    Type: Application
    Filed: May 27, 2003
    Publication date: February 19, 2004
    Inventors: Marisabel Mourelle Mancini, Juan Carlos Del Castillo Nieto, Berta Esperanza Lasheras Aldaz, Antonio Monge Vega, Joaquin Del Rio Zambrana
  • Publication number: 20030100598
    Abstract: New esters derived from substituted phenyl-cyclohexyl compounds, which are derived from Tramadol, process for obtaining them and their use for preparing a drug with analgesic properties. These new compounds of general formula (I) have a higher analgesic activity, a lower toxicity and a longer effective time period than Tramadol.
    Type: Application
    Filed: June 27, 2002
    Publication date: May 29, 2003
    Inventors: Marisabel Mourelle Mancini, Elisabet De Ramon Amat, Juan Huguet Clotet
  • Patent number: 6455585
    Abstract: New esters derived from substituted phenyl-cyclohexyl compounds, which are derived from Tramadol, process for obtaining them and their use for preparing a drug with analgesic properties. These new compounds of general formula (I) have a higher analgesic activity, a lower toxicity and a longer effective time period than Tramadol.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: September 24, 2002
    Assignee: Vita Invest, S.A.
    Inventors: Juan Carlos Del Castillo Nieto, Joan Huguet Clotet, Elisabet De Ramon Amat, Maria Chalaux Freixa, Marisabel Mourelle Mancini